“The vaccine does not contain a live virus, there will be no genetic material in the vaccine,” RIA Novosti quotes Gunzburg.

He also clarified that the new drug will be two-component.

Earlier Gunzburg said that in the center of them.

Gamaleyas are preparing for clinical trials of a coronavirus vaccine based on the Omicron and Delta strains.

The Ministry of Health of Russia approved the conduct of clinical trials of phases I-II of a vaccine against coronavirus containing virus-like particles.